Achieve Life Sciences, Inc.
ACHV
$5.10
$0.255.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.65% | -1.53% | -13.55% | 0.85% | -3.78% |
| Total Depreciation and Amortization | 0.00% | 5.56% | -1.82% | -11.29% | 6.90% |
| Total Amortization of Deferred Charges | 9.09% | -15.38% | -7.14% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -168.55% | -42.15% | -18.06% | 28.50% | 37.21% |
| Change in Net Operating Assets | 186.22% | -903.69% | 0.34% | 190.15% | -146.94% |
| Cash from Operations | 61.44% | -58.65% | -24.94% | 18.21% | -20.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,916.38% | 105.60% | -288.78% | -40.96% | -3.11% |
| Cash from Investing | 1,913.54% | 105.60% | -288.78% | -40.96% | -3.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.34% | -68.75% | -90.19% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.66% | 54.95% | -90.19% | -- | -- |
| Foreign Exchange rate Adjustments | -125.00% | 500.00% | -150.00% | 200.00% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.94% | 44.84% | -151.33% | 14,674.90% | -91.80% |